Clinical trials for lung cancer
130 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT04924075
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille), Hôpital Bicêtre AP-HP (Le Kremlin-Bicêtre), Hôpital Cochin (Paris ), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg) (and 1 more...)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT04868877
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
Systemic Treatment-Naive
Clinique de l'Europe d'Amiens (Amiens), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Albert Calmette de Lille (Lille) (and 7 more...)
Merus
Phase 2
Lung cancer
#NCT04868877
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Clinique de l'Europe d'Amiens (Amiens), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Albert Calmette de Lille (Lille) (and 7 more...)
Merus
Phase 2
Lung cancer
Colon cancer
Rectal cancer
#NCT04868877
Locally Advanced
Metastatic
Clinique de l'Europe d'Amiens (Amiens), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Albert Calmette de Lille (Lille) (and 7 more...)
Merus
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Kidney cancer
#NCT04705818
Locally Advanced
Metastatic
Metastatic Castration-resistant
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut Bergonié (Bordeaux)
Institut Bergonié
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
#NCT04657068
Locally Advanced
Metastatic
Metastatic Castration-resistant
ATM
Other mutation
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Phase 2
Lung cancer
#NCT05275478
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif)
Tango Therapeutics
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Locally Advanced
Immunotherapy
Surgery
Immunotherapy
Radiotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT06162221
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
KRAS non G12C
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nantes (Nantes) (and 1 more...)
Revolution Medicines, Inc.